| Latest Generex Biotechnology News Headlines | | Date | Time | Source | | | 10/15/2009 | 9:37AM | PRNUS | Weekly Digest's Investor Essentials Special Report Identifies Unique Investing Opportunities in the H1N1 'Swine Flu' Outbreak
PRINCETON, N.J., Oct. 15 /PRNewswire/ -- Weekly Digest (http://www.bullmarket.com/digest), a free investment research publication, announced the publication of a special report on investment opportunities in connection with the H1N1 "Swine Flu" Outbreak, including updated outlooks for Alpha Pro Tech (AMEX:APT), Novavax... More...>> |
| 06/15/2009 | 9:49AM | PRNUS | PennyStockExplosion.com Issues Technical Trade Alerts on Cancer Stocks on the Move Today: HEB, GNBT, CTIC, KERX, DNDN
BOSTON, June 15 /PRNewswire/ -- PennyStockExplosion.com is pleased to offer its stock alerts service to the investing community. Investors who are interested in stocks on the move and in the news can receive FREE Alerts by visiting the following link: http://www.pennystockexplosion.com/
Today's focused alerts include:... More...>> |
| 06/11/2009 | 11:50AM | PRNUS | GlobalEquityReport.com Issues Cancer Stocks On The Move Today: HEB, GNBT, CTIC, CTHP, DNDN
BOSTON, June 11 /PRNewswire/ -- GlobalEquityReport.com is pleased to offer its stock alerts service to the investing community. Investors who are interested in stocks on the move and in the news can receive FREE Alerts by visiting the following link: http://www.globalequityreport.com/
Today's focused alerts include:... More...>> |
| 04/28/2009 | 12:01PM | PRNUS | Tickerspy.com Announces New Stock Index Tracking Companies Seeking Treatments and Vaccines for Swine Flu and Avian Flu
PRINCETON, N.J., April 28 /PRNewswire/ -- Tickerspy (http://www.tickerspy.com/), an investing website featuring nearly 250 unique, proprietary Indexes, announced the creation of the Swine Flu and Bird Flu Stocks Index, which includes among its components Gilead Sciences (NASDAQ: GILD), Generex Biotechnology (NASDAQ:GNBT... More...>> |
| 04/28/2009 | 10:33AM | PRNUS | Antiviral Drugmaker Shares Soar as Swine Flu Spreads; Beacon Equity Issues Stock Alerts on: HEB, GNBT, BCRX, DVAX, NVAX, SVA
DALLAS, April 28 /PRNewswire/ -- BeaconEquity.com announces the availability of Stock Alerts on stocks making news today. As the influenza dominates the headlines, several biopharmaceutical stocks are parading up the charts.
So how does swine flu affect the markets? Check out a video chart for three stocks (BCRX, AVII... More...>> |
| 04/28/2009 | 7:00AM | PRNUS | Stock Preacher Issues Technical Trade Alerts on: AVII, SBUX, GNBT, GERN
VALLEY COTTAGE, N.Y., April 28 /PRNewswire/ -- StockPreacher.com announces the availability of Trade Alerts on stocks making news today.
Investors can view all of the daily updates for free by visiting: http://stockpreacher.com/
Today's Trade Alerts include: AVI BioPharma Inc. (NASDAQ:AVII) , Starbucks Corp. (NASDAQ:SBUX... More...>> |
| 08/20/2008 | 1:00PM | PRNUS | Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Generex Biotechnology Corporation
NEW YORK, Aug. 20 /PRNewswire/ -- Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview(R) (EIO(R)) on Generex Biotechnology Corporation (NASDAQ:GNBT). The full 64-page report can be found at http://www.crystalra.com/.
Generex Biotechnology Corporation ("Generex" or... More...>> |
| 07/30/2008 | 8:30AM | PRNUS | Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
BOSTON, July 30 /PRNewswire/ -- Scimitar Equity, LLC issues a review of Generex Biotechnology Corporation (NASDAQ:GNBT), entitled, "RapidMist(TM), the Non-Invasive Oral Drug Delivery Platform, Sets the Tone as Best in Class Followed by an Expanding Pipeline and Global Revenues."
This review is available at website:... More...>> |
| 02/07/2007 | 7:45AM | PRNUS | Frost & Sullivan Acknowledges Generex's Path-breaking Innovations in Oral Insulin Spray Technology
PALO ALTO, Calif., Feb. 7 /PRNewswire/ -- Frost & Sullivan selected Generex Biotechnology Corporation (NASDAQ:GNBT) as the recipient of the 2006 Frost & Sullivan Award for Technology Innovation in the field of diabetic therapies. The company's Generex Oral-lyn(TM), a breakthrough oral insulin spray technology for the... More...>> |
| 12/07/2006 | 9:35AM | PRNUS | Generex Biotechnology Selects Inyx to Produce Glucose RapidSpray(TM) for Worldwide Markets
NEW YORK, Dec. 7 /PRNewswire-FirstCall/ -- Generex Biotechnology Corporation (NASDAQ:GNBT), a leader in treating metabolic diseases via drug delivery through the inner lining of the mouth, and Inyx, Inc. (OTC:IYXI) (BULLETIN BOARD: IYXI) , a specialty pharmaceutical company focused on niche drug-delivery technologies... More...>> |
| 03/09/2006 | 8:00AM | PRNUS | The Bull Market Report Investigates Companies Involved in Bird Flu Research
PRINCETON, N.J., March 9 /PRNewswire/ -- The Bull Market Report (http://www.bullmarket.com/), an online investment newsletter focused on long- term growth and income-generating stocks, announced that it has published an in-depth report on companies involved in bird flu research, highlighting Hemispherx Biopharma (AMEX:HEB... More...>> |
| 10/28/2005 | 11:46AM | PRNUS | Generex Biotechnology Receives $6.4 Million From Warrant Exercises
Company now has additional funding available for the launch of commercial sales of Oral-lyn(TM) in Ecuador, Phase III / IV clinical trials of Oral-lyn(TM) in Canada and Europe, and the Antigen Express avian flu vaccine project
TORONTO, Oct. 28 /PRNewswire-FirstCall/ -- Generex Biotechnology Corporation (NASDAQ:GNBT... More...>> |
| 10/04/2005 | 9:00AM | PRNUS | Generex Biotechnology Presents Clinical Trial Results at Scientific Symposia
TORONTO, Oct. 4 /PRNewswire-FirstCall/ -- Generex Biotechnology Corporation (NASDAQ:GNBT), a leader in the area of buccal drug delivery, today announced that Dr. Jaime Guevara-Aguirre, of the Institute of Endocrinology IEMYR in Quito, Ecuador and one of the principal investigators in the Company's on-going clinical... More...>> |
| 09/29/2005 | 9:00AM | PRNUS | Generex Biotechnology Initiates Scale-up Commercial Production Run of Oral-lyn(TM)
TORONTO, Sept. 29 /PRNewswire/ -- Generex Biotechnology Corporation (NASDAQ:GNBT), a leader in the area of buccal drug delivery, announced today that it has initiated a scale-up commercial production run of Oral-lyn(TM), the Company's proprietary oral insulin buccal spray product. Earlier this week Generex commenced... More...>> |
| 09/28/2005 | 9:21AM | PRNUS | Generex Biotechnology Issues Webcast Follow-Up
TORONTO, Sept. 28 /PRNewswire-FirstCall/ -- Generex Biotechnology Corporation (NASDAQ:GNBT) announced today that, as a follow-up to the Company's presentations of clinical data at recent European-based scientific conferences, it hosted a press conference yesterday afternoon at its Toronto offices for approximately 20... More...>> |
| 09/27/2005 | 11:33AM | PRNUS | Generex Biotechnology Corp. to Host Call Today to Update Investors on Commercialization of Oral-lyn(TM)
Conference Call and Webcast to Take Place at 2 pm Eastern Time today
TORONTO, Sept. 27 /PRNewswire-FirstCall/ -- Generex Biotechnology Corporation (NASDAQ:GNBT), a leader in the area of buccal drug delivery, announced today that it will hold a conference call and webcast at 2 pm eastern time today to update interested... More...>> |
| 09/27/2005 | 8:30AM | PRNUS | Generex Biotechnology Appoints VP of Regulatory Affairs for Latin & South America
Company Augments Managerial Expertise in Connection with the Commercialization of Oral-lyn(TM)
TORONTO, Sept. 27 /PRNewswire-FirstCall/ -- Generex Biotechnology Corporation (NASDAQ:GNBT), a leader in the area of buccal drug delivery, today announced that Dr. Camilo Felix Gallegos has accepted an appointment as the Company's... More...>> |
| 09/20/2005 | 9:37AM | PRNUS | Generex Biotechnology Clinician To Present Clinical Trial Results at The ESPE/LWPES 7th Joint Meeting Paediatric Endocrinology
TORONTO, Sept. 20 /PRNewswire-FirstCall/ -- Generex Biotechnology Corporation (NASDAQ:GNBT), a leader in the area of buccal drug delivery, today announced that Dr. Jaime Guevara-Aguirre, of the Institute of Endocrinology IEMYR in Quito, Ecuador and one of the principal investigators in the Company's on-going clinical... More...>> |
| 09/15/2005 | 1:00PM | PRNUS | Generex Biotechnology Presents Additional Immunotherapeutics Study Results at the 41st Annual Meeting of the European Associatio
TORONTO, Sept. 15 /PRNewswire-FirstCall/ -- Generex Biotechnology Corporation (NASDAQ:GNBT), a leader in the area of buccal drug delivery, today announced further clinical trial results generated by Antigen Express, Inc., the Company's wholly-owned immunotherapeutics subsidiary.
Marta Vadacca of Universita Campus Bio-Medico... More...>> |
| 09/15/2005 | 9:11AM | PRNUS | Generex Biotechnology Presents Immunotherapeutics Study Results at the 41st Annual Meeting of the European Association for the S
TORONTO, Sept. 15 /PRNewswire-FirstCall/ -- Generex Biotechnology Corporation (NASDAQ:GNBT), a leader in the area of buccal drug delivery, today announced clinical trial results generated by Antigen Express, Inc., the Company's wholly-owned immunotherapeutics subsidiary.
Marta Vadacca of Universita Campus Bio-Medico... More...>> |
|